MicroPort NeuroScientific Corporation Announces Scrip Dividend Election for Final Dividend FY2025
Key Points Investors Must Know
- Scrip Dividend Election Form Released: MicroPort NeuroScientific Corporation (Stock Code: 2172) has issued its scrip dividend election form for the final dividend for the year ended 31 December 2025.
-
Dividend Options: Shareholders are offered a choice for receiving the final dividend:
- Scrip Shares: Investors can elect to receive new shares (Scrip Shares of US\$0.00002 each) instead of cash.
- Cash Dividend: Shareholders can opt for a cash dividend by simply taking no action (i.e., NOT returning the election form).
- Combination: Investors may receive part of their dividend in cash and part in Scrip Shares, by specifying the number of shares for which they want Scrip Shares in Box C of the form.
- Election Deadline: The completed election form must be submitted to Computershare Hong Kong Investor Services Limited by 4:30 p.m. on Thursday, 6 August 2026.
- Record Date: The relevant shareholding for the dividend entitlement is based on the Record Date, 8 July 2026.
- Important Clarification: If the shareholder elects Scrip Shares for more shares than held on the Record Date, the company will treat the election as for all shares held, and the entire dividend will be paid in Scrip Shares.
-
Price Sensitivity: The choice between scrip and cash dividend can affect the company’s share price:
- Share Dilution: If a large proportion of shareholders opt for Scrip Shares, the issued share capital will increase, potentially diluting earnings per share and affecting the share price.
- Investor Confidence: A large uptake of Scrip Shares may indicate investor confidence in the company’s future and growth prospects.
- Liquidity Considerations: Scrip dividends may increase liquidity in the stock, as more shares become available for trading.
- Action Required: Shareholders wishing to receive Scrip Shares or a combination must complete and sign the election form (with signatures matching registrar records) and submit it before the deadline. Joint shareholders must all sign.
- Consequence of Inaction: Failure to return a completed form means the dividend will be paid entirely in cash.
- Contact Details: The election form must be returned to Computershare Hong Kong Investor Services Limited, Shops 1712–1716, 17th Floor, Hopewell Centre, 183 Queen’s Road East, Hong Kong.
Implications for Shareholders and Share Price
The announcement is significant for investors as it offers flexibility in dividend payment. Scrip dividends can be a sign of capital preservation and future growth, while increased share issuance may impact share price due to dilution. Investors should carefully consider their election, as their choice can influence both their returns and the company’s capital structure.
Investor Reminder
Deadline: 6 August 2026, 4:30 p.m.
Record Date: 8 July 2026
Disclaimer
This article is for informational purposes only and does not constitute investment advice. Investors are encouraged to review the official circular and consult their financial advisors before making any decisions. The information provided may be subject to change and should not be relied upon for investment purposes.
微創神經科學公司公布2025年度末期股息紅股選擇詳情
投資者必須注意的關鍵點
- 紅股選擇表格發佈： 微創神經科學公司（股票代號：2172）已發佈2025年12月31日止年度末期股息的紅股選擇表格。
-
股息選擇： 股東可選擇以下方式收取末期股息：
- 紅股： 股東可選擇以紅股（每股0.00002美元）代替現金收取末期股息。
- 現金股息： 若股東希望收取現金股息，無需採取任何行動（即不需交還選擇表格）。
- 部分紅股、部分現金： 股東可在表格Box C填寫希望以紅股收取的股份數量，其餘將以現金形式派發。
- 選擇截止： 填妥的選擇表格須於2026年8月6日（星期四）下午4時30分前交回香港電腦股份登記有限公司。
- 記錄日： 股息權益以2026年7月8日的股份持有情況為準。
- 重要提醒： 若股東申請以紅股收取股息的股份數多於記錄日持有的股份，公司將按全部持股發放紅股股息。
-
價格敏感： 紅股選擇可能影響公司股價：
- 股份攤薄： 若大量股東選擇紅股，公司流通股本將增加，可能攤薄每股盈利，影響股價。
- 投資者信心： 大量股東選擇紅股或反映對公司前景有信心。
- 流通量： 紅股派發可能增加股份流通量，提升市場流動性。
- 所需行動： 股東如需紅股或部分紅股，必須填妥並簽署選擇表格（簽名須與股份登記資料一致），聯名股東須全部簽名。
- 未採取行動： 未交回表格者，股息將全面以現金派發。
- 聯絡地址： 選擇表格須交回香港電腦股份登記有限公司，地址：香港皇后大道東183號合和中心17樓1712–1716號舖。
對股東及股價的影響
此公告為投資者提供靈活股息選擇，紅股派發既可保存資本，又反映公司成長潛力，但股份增加亦可能對股價構成壓力。投資者應審慎考慮選擇，因其決定會影響回報及公司資本結構。
投資者提醒
截止日期： 2026年8月6日下午4時30分
記錄日： 2026年7月8日
免責聲明
本文章僅供資訊參考，並不構成任何投資建議。投資者應細閱公司通函及諮詢財務顧問作出決策。資料或會變動，請勿作為投資依據。
